Stay updated with breaking news from Bio Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investment analysts at StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the stock. Separately, Roth Capital reaffirmed a “buy” rating on shares of Bio-Path in a research note on Friday, March 17th. Bio-Path Stock Performance NASDAQ BPTH […]
StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report report published on Tuesday morning. The brokerage issued a sell rating on the stock. Separately, Roth Capital reissued a buy rating on shares of Bio-Path in a research report on Friday, March 17th. Bio-Path Trading Up 2.7 % Shares of […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Rating) saw a significant decline in short interest during the month of April. As of April 30th, there was short interest totalling 70,400 shares, a decline of 15.8% from the April 15th total of 83,600 shares. Based on an average trading volume of 31,100 shares, the days-to-cover ratio is […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Rating) saw a significant drop in short interest during the month of April. As of April 30th, there was short interest totalling 70,400 shares, a drop of 15.8% from the April 15th total of 83,600 shares. Based on an average daily trading volume, of 31,100 shares, the short-interest ratio […]
StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a report released on Monday morning. The brokerage issued a sell rating on the stock. Separately, Roth Capital restated a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Up 0.6 % BPTH opened at $1.52 on […]